German Study Finds Most New Drugs Fail to Improve on Standard of Care
A study in The BMJ by officials from Germany’s Institute of Quality and Efficiency in Healthcare (IQWiG) finds there is no evidence of added benefit...
Continue ReadingGUBBA PHARMA IN E NEWS
Dr Reddy’s plan to launch value-added drugs in US
Dr Reddy’s Laboratories said that it plans to launch several value-added products, to offset the persisting pricing pressure problem in the US market. As part...
Continue Reading
FDA Accepts Sanofi’s BLA for Meningitis Vaccine to Review
Sanofi SNY announced that the FDA has accepted for review its biologics license application (BLA) for MenQuadfi, a meningococcal vaccine candidate, currently being developed for...
Continue Reading
Maersk Spot unveiled as Danish carrier moves ahead with online box bookings
Maersk today unveiled the next chapter in its quest to lead liner shipping’s path to online container bookings. With the launch of Maersk Spot, the...
Continue Reading
AbbVie to acquire Botox maker Allergan for $63bn
US drugmaker AbbVie has agreed to buy Allergan, the Irish-domiciled maker of Botox, in a $63bn deal that is the sector’s latest blockbuster transaction driven...
Continue Reading
Bharat Biotech to collaborate with Hilleman to develop cholera vaccine
Hilleman Laboratories announced on Wednesday that it will collaborate with Hyderabad-based vaccine maker Bharat Biotech International Limited (BBIL) for further development, manufacture and commercialisation of...
Continue Reading
DuPont, BioMe Oxford to co-develop and bring to market smart capsule to sample gut microbiota
Intestinal microbiome, 3D illustration showing anatomy of human digestive system and enteric bacteria Escherichia coli, E. coli, colonizing jejunum, ileum, other parts of intestine. Gut...
Continue Reading
Pfizer opens new biologics clinical manufacturing facility in Massachusetts
Pfizer’s Andover site houses commercial manufacturing and product development functions, with colleagues dedicated to the development and production of high-quality complex biologics and vaccines. With...
Continue Reading
New Data Show Use of Abbott’s FreeStyle® Libre System Significantly Reduces HbA1c Levels in People Living with Type 2 Diabetes
Presented as a late-breaker at the American Diabetes Association (ADA) 79th Scientific Sessions, new real-world data demonstrate that monitoring glucose with FreeStyle Libre System has...
Continue Reading